Literature DB >> 29940177

Rnd3/RhoE expression is regulated by G-actin through MKL1-SRF signaling pathway.

Léo Piquet1, Terezinha Robbe1, Véronique Neaud1, Sara Basbous1, Stéphanie Rosciglione1, Frédéric Saltel1, Violaine Moreau2.   

Abstract

Rnd3/RhoE is an atypical member of the Rho family of small GTPases, devoid of intrinsic GTP hydrolytic activity and a general modulator of important cellular processes such as migration and proliferation. Here, we show that Rnd3 is a target of the transcription factor SRF and its co-activator MKL1. The MKL1-SRF pathway assures the translation of physical forces into a transcriptional response. Rho GTPases can modulate the activity of this mechanotransduction pathway through actin cytoskeleton regulation, and many MKL1-SRF targets are involved in the regulation of actin. We found that Rnd3 expression is altered by G-actin signaling and sensitive to actin-targeting drugs and MKL1 mutants. We further characterized a consensus SRF binding site in the Rnd3 promoter. We found that MKL1-SRF modulation regulates Rnd3 promoter activity and Rnd3 expression can affect MKL1-SRF pathway activity in return. We demonstrated that this novel MKL1-SRF target is required in mechanosensitive mechanisms such as cell spreading and spheroid formation. Thus, Rnd3 is a MKL1-SRF target that plays a key role in the feedback loop described between the MKL1-SRF pathway and the organization of the actin cytoskeleton.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Actin cytoskeleton; Rho GTPases; SRF; Transcription

Mesh:

Substances:

Year:  2018        PMID: 29940177     DOI: 10.1016/j.yexcr.2018.06.023

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  Effect of RhoE expression on the migration and invasion of tongue squamous cell carcinoma.

Authors:  Kai Zhao; Wen-Hong Yuan; Wen-Jian Li; Zeng-Peng Chi; Shao-Ru Wang; Zheng-Gang Chen
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-10-01

2.  NLK is required for Ras/ERK/SRF/ELK signaling to tune skeletal muscle development by phosphorylating SRF and antagonizing the SRF/MKL pathway.

Authors:  Shang-Ze Li; Ze-Yan Zhang; Jie Chen; Ming-You Dong; Xue-Hua Du; Jie Gao; Qi-Peng Shu; Chao Li; Xin-Yi Liang; Zhi-Hao Ding; Run-Lei Du; Junli Wang; Xiao-Dong Zhang
Journal:  Cell Death Discov       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.